10 Overlooked Penny Stocks to Buy Right Now
The article cites Reuters (June 30, 2026) on market tests for sustaining the 2026 rally, including AI spending, earnings expectations, and Fed policy. It then lists penny stocks, focusing on Petco (WOOF) and Lithium Americas (LAC): WOOF reported Q1 2026 net sales $1.5B and guided FY 2026 adj. EBITDA $415–$430M; LAC reported progress toward Thacker Pass mechanical completion in late 2027 and targets 2026 capex $1.3–$1.6B. Analyst price targets were updated for both.
How this was made
The 30-second read
Why it matters
It provides company-specific operational updates and guidance ranges for two names, plus analyst target changes, but does not add new, same-day decision catalysts beyond those dated events.
Market read
Traders can use the disclosed Q1 operating metrics and project milestones to reassess near-term risk/reward, but the article’s “buy right now” framing is not a fresh catalyst.
What to watch
For WOOF, the key swing factor is whether the first positive comp in five quarters can persist; for LAC, the market may discount milestone progress if operating efficiency or construction cost overruns remain unresolved.
Background
The article sets a macro backdrop (AI capex durability, earnings expectations, and Fed policy under a new chairman) and then pivots to a screened list of sub-$5 stocks with analyst-implied upside.
Ticker impact
Petco reported Q1 2026 results with first positive comparable sales in five quarters and reaffirmed 2026 adjusted EBITDA guidance.
Moderate upside bias if investors view the positive comp and margin expansion as durable; downside risk if guidance/EBITDA expectations slip again.
The article provides concrete Q1 operating metrics (comp sales, gross margin, operating income, adjusted EBITDA) plus reaffirmed full-year EBITDA range and subsequent PT changes from multiple banks.
Lithium Americas detailed Thacker Pass execution progress (engineering >95%, procurement >70%, cash levels) and reiterated 2026 capex targets.
Likely volatility with a slight positive tilt if investors credit progress toward late-2027 mechanical completion; negative if execution/efficiency risks dominate.
The article includes specific project milestones, workforce ramp, cash at JV and company level, and a fresh analyst initiation with a defined PT alongside the operational update.
Market effects
Highlights ongoing investor sensitivity to execution risk in lithium development and to consumer demand/EBITDA durability in retail services.
Primarily US small-cap sentiment; no explicit regional catalyst beyond broader US rate/earnings backdrop.
Lithium project progress can influence global EV/battery supply expectations, but the article is company-specific and not a market-wide supply shock.
Counterpoint
The article is a marketing-style “overlooked penny stocks” list; the newest actionable catalysts are limited to already-dated Q1 results and analyst PT adjustments rather than fresh prints today.
Key entities
- companyPetco Health and Wellness Company, Inc.
Reported Q1 2026 results with first positive comparable sales in five quarters and reaffirmed full-year 2026 adjusted EBITDA guidance.
- companyLithium Americas Corp.
Provided Thacker Pass execution progress and reiterated 2026 capex targets alongside an analyst initiation with a price target.
- Fed officialKevin Warsh
New Fed chairman referenced as a source of potential near-term rate-hike risk in the macro backdrop.
